We have developed C-STEMTM : a proprietary technology for the mass-production of cell therapies.
A series of proprietary cell therapy programs for co-development or licensing
PRESS RELEASE TreeFrog Therapeutics raises over €7M ($7.8M) in Series A financing round 6 months after incorporation Funding to scale-up company’s proprietary technology C-Stem™ for mass-production of safe and affordable cell therapies Bordeaux, France, May 13, 2019 – TreeFrog Therapeutics, an expert stem......
13 May, 2019 News Press
We will be at booth P8 ! Let’s discuss cell therapy mass production there ! Learn about the event...
07 May, 2019 Events News
C- Stem™ technology introduces a new standard for hIPS suspension culture. Based on biomimetic stem cell culture in 3D, C- Stem™ enables cell therapy production scale-up while ensuring genomic and phenotypic stability Bordeaux, France, April 16, 2019 – TreeFrog Therapeutics, an expert stem......
15 April, 2019 News PressI am test text for Image with text shortcode. |
TreeFrog Therapeutics is a French stem cell company aiming at supporting the advent and industrial development of stem cell therapies.